Home/Skye Bioscience/Chief Operating Officer (COO)
CO

Chief Operating Officer (COO)

Chief Operating Officer

Skye Bioscience

Therapeutic Areas

Skye Bioscience Pipeline

DrugIndicationPhase
NimacimabObesity (combination therapy)Phase 2
CB1 Receptor Inhibitor(s)Obesity / Metabolic DiseasesR&D